CommercialAdministrativeMedium impact
HEDIS® Follow-Up Care for Children Prescribed ADHD Medication (ADD)
Blue Cross Blue Shield of Rhode Island·RI · Pediatrics, Family Medicine, Psychiatry·Behavioral Health
Effective date
Aug 1, 2022
We identified it
Jun 19, 2026
Summary
BCBS Rhode Island has established HEDIS quality measure requirements for follow-up care of children prescribed ADHD medication. Children newly prescribed ADHD medication must have at least three follow-up visits within 10 months, with one visit within 30 days of first medication dispensing.
Action Required
Providers treating children with ADHD must ensure proper follow-up scheduling: Schedule first follow-up visit within 30 days of ADHD medication dispensing and ensure at least three total follow-up visits within 10 months. Update EMR templates to track HEDIS ADD measure compliance for quality reporting.